Podcast: Minimizing Toxicity of Treatments for B Cell Lymphoma
MEI's drug candidate zandelisib is a P13K delta inhibitor. It is being studied in lymphoma in B cells.
Recent Podcasts
- Oct 19, 2021
- 1 min
Podcast: Developing Inhibitor Drugs for Use with Antibiotics to Combat Antimicrobial Drug Resistance
Qpex is developing IV and oral drugs to overcome resistance mechanisms in bacteria that render penicillin-like drugs inactive.
- Oct 10, 2021
- 1 min
Pocast: Focusing on Health Equity to Sustain a More Resilient Population: Sam Meraj of Walmart
I think a lot is being done to address health equity, but yet we have an opportunity to do a lot more.
